Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: A role for cholinergic transmission

Neuroscience

Volumn 131, Issue 2, 2005, Pages 375-385

  Wisor, J P ^a,d   Edgar, D M ^a   Yesavage, J ^a,b,c   Ryan, H S ^a,c   Mccormick, C M ^a   Lapustea, N ^a   Murphy Jr , G M ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SRI INTERNATIONAL   (United States)

Author keywords

Amyloid precursor protein; Donepezil; Electroencephalogram; Sleep deprivation; Tg2576; amyloid immunization

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; DONEPEZIL; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC TRANSMISSION; CIRCADIAN RHYTHM SLEEP DISORDER; CONTROLLED STUDY; DARKNESS; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; FEMALE; IMMUNIZATION; MALE; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; REM SLEEP; RUNNING; SLEEP DEPRIVATION; TRANSGENIC MOUSE; WAKEFULNESS; WILD TYPE;

EID: 13544275103     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.11.018     Document Type: Article

References (75)

1. J. Apelt, A. Kumar, R. Schliebs Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein Brain Res 953 2002 17
2. G.W. Arendash, D.L. King Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls Physiol Behav 75 2002 643 652
3. G. Aston-Jones, S. Chen, Y. Zhu, M.L. Oshinsky A neural circuit for circadian regulation of arousal Nat Neurosci 4 2001 732 738
4. W.C. Benzing, J.R. Wujek, E.K. Ward, D. Shaffer, K.H. Ashe, S.G. Younkin, K.R. Brunden Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice Neurobiol Aging 20 1999 581 589
5. M. Bigl, J. Apelt, K. Eschrich, R. Schliebs Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology J Neural Transm 110 2003 77 94
6. K.G. Bina, B. Rusak Muscarinic receptors mediate carbachol-induced phase shifts of circadian activity rhythms in Syrian hamsters Brain Res 743 1996 202 211
7. K.G. Bina, B. Rusak, K. Semba Localization of cholinergic neurons in the forebrain and brainstem that project to the suprachiasmatic nucleus of the hypothalamus in rat J Comp Neurol 335 1993 295 307
8. D.L. Bliwise Dementia M.H. Kryger Principles and practice of sleep medicine 2000 W.B. Saunders Philadelphia 1058 1071
9. M.J. Callahan, W.J. Lipinski, F. Bian, R.A. Durham, A. Pack, L.C. Walker Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice Am J Pathol 158 2001 1173 1177
10. E.G. Cape, I.D. Manns, A. Alonso, A. Beaudet, B.E. Jones Neurotensin-induced bursting of cholinergic basal forebrain neurons promotes gamma and theta cortical activity together with waking and paradoxical sleep J Neurosci 20 2000 8452 8461
11. T.C. Chou, T.E. Scammell, J.J. Gooley, S.E. Gaus, C.B. Saper, J. Lu Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms J Neurosci 23 2003 10691 10702
12. B.J. Cummings, C.J. Pike, R. Shankle, C.W. Cotman Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease Neurobiol Aging 17 1996 921 933
13. Dodart Immunization reverses memory deficits without reducing Abeta burden in Alzheimer's disease model Nat Neurosci 5 2002 452 457
14. D.M. Edgar, T.S. Kilduff, C.E. Martin, W.C. Dement Influence of running wheel activity on free-running sleep/wake and drinking circadian rhythms in mice Physiol Behav 50 1991 373 378
15. Y. Endo, K. Shinohara, Y. Fueta, M. Irie Influences of cholinergic neurotoxin ethylcholine aziridinium ion on circadian rhythms in rats Neurosci Res 41 2001 385 390
16. P. Etienne, Y. Robitaille, P. Wood, S. Gauthier, N.P. Nair, R. Quirion Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease Neuroscience 19 1986 1279 1291
17. D.G. Flood, A.G. Reaume, K.S. Dorfman, Y.G. Lin, D.M. Lang, S.P. Trusko, M.J. Savage, W.G. Annaert, B. De Strooper, R. Siman, R.W. Scott FAD mutant PS-1 gene-targeted mice increased A beta 42 and A beta deposition without APP overproduction Neurobiol Aging 23 2002 335 348
18. P. Franken, A. Malafosse, M. Tafti Genetic variation in EEG activity during sleep in inbred mice Am J Physiol 44 1998 R1127 R1137
19. D.C. German, U. Yazdani, S.G. Speciale, P. Pasbakhsh, D. Games, C.L. Liang Cholinergic neuropathology in a mouse model of Alzheimer's disease J Comp Neurol 462 2003 371 381
20. E. Giacobini Cholinergic function and Alzheimer's disease Int J Geriatr Psychiatry 18 2003 S1 S5
21. E. Goudsmit, M.A. Hofman, E. Fliers, D.F. Swaab The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease Neurobiol Aging 11 1990 529 536
22. L. Graves, A. Pack, T. Abel Sleep and memory a molecular perspective Trends Neurosci 24 2001 237 243
23. T. Harkany, S. O'Mahony, J. Keijser, J.P. Kelly, C. Konya, Z.A. Borostyankoi, T.J. Gorcs, M. Zarandi, B. Penke, B.E. Leonard, P.G. Luiten Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex Neurobiol Dis 8 2001 667 678
24. T. Harkany, B. Penke, P.G. Luiten beta-Amyloid excitotoxicity in rat magnocellular nucleus basalis effect of cortical deafferentation on cerebral blood flow regulation and implications for Alzheimer's disease Ann NY Acad Sci 903 2000 374 386
25. K. Hsiao Transgenic mice expressing Alzheimer amyloid precursor proteins Exp Gerontol 33 1998 883 889
26. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
27. K.K. Hsiao, D.R. Borchelt, K. Olson, R. Johannsdottir, C. Kitt, W. Yunis, S. Xu, C. Eckman, S. Younkin, D. Price Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins Neuron 15 1995 1203 1218
28. S. Huitron-Resendiz, M. Sanchez-Alavez, R. Gallegos, G. Berg, E. Crawford, J.L. Giacchino, D. Games, S.J. Henriksen, J.R. Criado Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice Brain Res 928 2002 126 137
29. M.C. Irizarry, M. McNamara, K. Fedorchak, K. Hsiao, B.T. Hyman APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1 J Neuropathol Exp Neurol 56 1997 965 973
30. B.E. Jones Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex Prog Brain Res 145 2004 157 169
31. T. Kawarabayashi, M. Shoji, L.H. Younkin, L. Wen-Lang, D.W. Dickson, T. Murakami, E. Matsubara, K. Abe, K.H. Ashe, S.G. Younkin Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by Apolipoprotein E and phosphorylated tau accumulation in the Tg2576 model of Alzheimer's disease J Neurosci 24 2004 3801 3809
32. D.L. King, G.W. Arendash, F. Crawford, T. Sterk, J. Menendez, M.J. Mullan Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease Behav Brain Res 103 1999 145 162
33. M. Klingner, J. Apelt, A. Kumar, D. Sorger, O. Sabri, J. Steinbach, M. Scheunemann, R. Schliebs Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology Int J Dev Neurosci 21 2003 357 369
34. L.A. Kotilinek, B. Bacskai, M. Westerman, T. Kawarabayashi, L. Younkin, B.T. Hyman, S. Younkin, K.H. Ashe Reversible memory loss in a mouse transgenic model of Alzheimer's disease J Neurosci 22 2002 6331 6335
35. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, G.M. Cole The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J Neurosci 21 2001 8370 8377
36. C. Liu, M.U. Gillette Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night J Neurosci 16 1996 744 751
37. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
38. S.M. McCurry, C.F. Reynolds, S. Ancoli-Israel, L. Teri, M.V. Vitiello Treatment of sleep disturbance in Alzheimer's disease Sleep Med Rev 4 2000 603 628
39. K. Mishima, M. Okawa, K. Satoh, T. Shimizu, S. Hozumi, Y. Hishikawa Different manifestations of circadian rhythms in senile dementia of Alzheimer's type and multi- infarct dementia Neurobiol Aging 18 1997 105 109
40. O.M. Mitrasinovic, G.M. Murphy Jr Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Abeta Neurobiol Aging 24 2003 807 815
41. G.M. Murphy Jr, L.S. Forno, L. Higgins, J.M. Scardina, L.F. Eng, B. Cordell Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders Am J Pathol 144 1994 1082 1088
42. K. Noda-Saita, K. Terai, A. Iwai, M. Tsukamoto, Y. Shitaka, S. Kawabata, M. Okada, T. Yamaguchi Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease Acta Neuropathol (Berl) 108 2004 435 442
43. H. Ogura, T. Kosasa, Y. Kuriya, Y. Yamanishi Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats Eur J Pharmacol 415 2001 157 164
44. M. Ohno, E.A. Sametsky, L.H. Younkin, H. Oakley, S.G. Younkin, M. Citron, R. Vassar, J.F. Disterhoft BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease Neuron 41 2004 27 33
45. M. Onofrj, A. Thomas, D. Iacono, A.L. Luciano, A. Di Iorio The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition a part 3 study of the main mechanism of cholinesterase inhibitors in dementia Clin Neuropharmacol 26 2003 239 251
46. M.L. Perlis, M.T. Smith, H.J. Orff, P.J. Andrews, J.C. Gillin, D.E. Giles The effects of an orally administered cholinergic agonist on REM sleep in major depression Biol Psychiatry 51 2002 457 462
47. C.P. Pollak, D. Perlick, J.P. Linsner, J. Wenston, F. Hsieh Sleep problems in the community elderly as predictors of death and nursing home placement J Community Health 15 1990 123 135
48. T. Porkka-Heiskanen Adenosine in sleep and wakefulness Ann Med 31 1999 125 129
49. T. Porkka-Heiskanen, R.E. Strecker, M. Thakkar, A.A. Bjorkum, R.W. Greene, R.W. McCarley Adenosine a mediator of the sleep-inducing effects of prolonged wakefulness Science 276 1997 1265 1268
50. R. Quirion, J.C. Martel, Y. Robitaille, P. Etienne, P. Wood, N.P. Nair, S. Gauthier Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type Can J Neurol Sci 13 1986 503 510
51. A.G. Reaume, D.S. Howland, S.P. Trusko, M.J. Savage, D.M. Lang, B.D. Greenberg, R. Siman, R.W. Scott Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Abeta sequence J Biol Chem 271 1996 23380 23388
52. C.F. Reynolds 3rd, C.C. Hoch, J. Stack, D. Campbell The nature and management of sleep/wake disturbance in Alzheimer's dementia Psychopharmacol Bull 24 1988 43 48
53. A. Satlin, L. Volicer, E.G. Stopa, D. Harper Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease Neurobiol Aging 16 1995 765 771
54. M.J. Savage, Y.G. Lin, J.R. Ciallella, D.G. Flood, R.W. Scott Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition J Neurosci 22 2002 3376 3385
55. W.J. Schwartz, P. Zimmerman Circadian timekeeping in BALB/C and C57BL/6 inbred mouse strains J Neurosci 10 1990 3686 3694
56. K. Semba, H.C. Fibiger Organization of central cholinergic systems Prog Brain Res 79 1989 37 63
57. P.J. Shiromani, D. Overstreet Free-running period of circadian rhythms is shorter in rats with a genetically upregulated central cholinergic system Biol Psychiatry 36 1994 622 626
58. D.G. Standaert, V.M. Lee, B.D. Greenberg, D.E. Lowery, J.Q. Trojanowski Molecular features of hypothalamic plaques in Alzheimer's disease Am J Pathol 139 1991 681 691
59. M. Steriade Acetylcholine in the cerebral cortex Prog Brain Res 145 2004 179 196
60. R.E. Strecker, S. Morairty, M.M. Thakkar, T. Porkka-Heiskanen, R. Basheer, L.J. Dauphin, D.G. Rainnie, C.M. Portas, R.W. Greene, R.W. McCarley Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state Behav Brain Res 115 2000 183 204
61. D.F. Swaab, B. Fisser, W. Kamphorst, D. Troost The human suprachiasmatic nucleus; neuropeptide changes in senium and Alzheimer's disease Basic Appl Histochem 32 1988 43 54
62. B. Tate, K.S. Aboody-Guterman, A.M. Morris, E.C. Walcott, R.E. Majocha, C.A. Marotta Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid Proc Natl Acad Sci USA 89 1992 7090 7094
63. K. Terai, A. Iwai, S. Kawabata, M. Sasamata, K. Miyata, T. Yamaguchi Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse implications for the pathogenesis of Alzheimer's disease Brain Res 900 2001 48 56
64. O.A. Timofeeva, C.J. Gordon EEG spectra, behavioral states and motor activity in rats exposed to acetylcholinesterase inhibitor chlorpyrifos Pharmacol Biochem Behav 72 2002 669 679
65. J.Q. Trojanowski The cellular and molecular correlates of cognitive impairments in the Alzheimer's disease brain Neurobiol Aging 17 1996 941 943
66. A.N. van den Pol, K.L. Tsujimoto Neurotransmitters of the hypothalamic suprachiasmatic nucleus immunocytochemical analysis of 25 neuronal antigens Neuroscience 15 1985 1049 1086
67. R.N. Van Gelder, D.M. Edgar, W.C. Dement Real-time automated sleep scoring validation of a microcomputer-based system for mice Sleep 14 1991 48 55
68. M.V. Vitiello, J.S. Poceta, P.N. Prinz Sleep in Alzheimer's disease and other dementing disorders Can J Psychol 45 1991 221 239
69. L. Volicer, D.G. Harper, B.C. Manning, R. Goldstein, A. Satlin Sundowning and circadian rhythms in Alzheimer's disease Am J Psychiatry 158 2001 704 711
70. G.L. Wenk Neuropathologic changes in Alzheimer's disease J Clin Psychiatry 64 Suppl 9 2003 7 10
71. M.A. Westerman, D. Cooper-Blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi, L.H. Younkin, G.A. Carlson, S.G. Younkin, K.H. Ashe The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease J Neurosci 22 2002 1858 1867
72. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, M.R. Delon Alzheimer's disease and senile dementia loss of neurons in the basal forebrain Science 215 1982 1237 1239
73. J.P. Wisor Disorders of the circadian clock etiology and possible therapeutic targets Curr Drug Targets CNS Neurolog Disord 1 2002 555 566
74. J.P. Wisor, S. Nishino, I. Sora, G.H. Uhl, E. Mignot, D.M. Edgar Dopaminergic role in stimulant-induced wakefulness J Neurosci 21 2001 1787 1794
75. J.P. Wisor, B.F. O'Hara, A. Terao, C.P. Selby, T.S. Kilduff, A. Sancar, D.M. Edgar, P. Franken A role for cryptochromes in sleep regulation BMC Neurosci 3 2002 20